STOCK TITAN

[144] Alector, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Alector, Inc. (ALEC) submitted a Form 144 reporting a proposed sale of 76,446 common shares with an aggregate market value of $152,892.00, against 101,212,329 shares outstanding. The filing states the shares were acquired as restricted stock on 03/01/2023 and lists an approximate sale date of 08/08/2025 on NASDAQ through Morgan Stanley Smith Barney LLC. The notice also discloses a prior sale of 16,488 shares on 06/02/2025 for gross proceeds of $22,065.89. The signer represents there is no undisclosed material adverse information and includes standard Rule 144 attestations.

Alector, Inc. (ALEC) ha presentato un Form 144 segnalando la proposta di vendita di 76,446 azioni ordinarie per un valore di mercato complessivo di $152,892.00, su 101,212,329 azioni in circolazione. Il deposito indica che le azioni sono state acquisite come restricted stock il 03/01/2023 e riporta una data approssimativa di vendita del 08/08/2025 sul NASDAQ tramite Morgan Stanley Smith Barney LLC. L'avviso segnala inoltre una precedente vendita di 16,488 azioni il 06/02/2025 per proventi lordi di $22,065.89. Il sottoscrittore dichiara che non esistono informazioni sfavorevoli materiali non divulgate e include le attestazioni standard previste dalla Rule 144.

Alector, Inc. (ALEC) presentó un Form 144 informando una propuesta de venta de 76,446 acciones comunes por un valor de mercado agregado de $152,892.00, de un total de 101,212,329 acciones en circulación. La presentación indica que las acciones fueron adquiridas como restricted stock el 03/01/2023 y señala una fecha aproximada de venta del 08/08/2025 en NASDAQ a través de Morgan Stanley Smith Barney LLC. El aviso también revela una venta anterior de 16,488 acciones el 06/02/2025 por ingresos brutos de $22,065.89. El firmante declara que no existe información adversa material no divulgada e incluye las atestaciones estándar de la Rule 144.

Alector, Inc. (ALEC)는 Form 144를 제출하여 총 시장 가치가 $152,892.0076,446 보통주 매각 예정 사실을 보고했으며, 발행 주식 수는 101,212,329입니다. 제출 문서에 따르면 해당 주식은 03/01/2023restricted stock으로 취득되었고, 08/08/2025NASDAQ을 통해 Morgan Stanley Smith Barney LLC에서 매각될 예정으로 기재되어 있습니다. 또한 공지에는 06/02/202516,488주를 매각하여 총수익 $22,065.89를 얻었다는 사실도 공개되어 있습니다. 서명인은 공개되지 않은 중대한 불리한 정보가 없음을 진술하며 Rule 144의 표준 확인서들을 포함합니다.

Alector, Inc. (ALEC) a déposé un Form 144 déclarant une vente proposée de 76,446 actions ordinaires pour une valeur marchande totale de $152,892.00, sur 101,212,329 actions en circulation. Le dossier précise que les actions ont été acquises en tant que restricted stock le 03/01/2023 et indique une date approximative de vente au 08/08/2025 sur le NASDAQ via Morgan Stanley Smith Barney LLC. L'avis divulgue également une vente antérieure de 16,488 actions le 06/02/2025 pour un produit brut de $22,065.89. Le signataire déclare l'absence d'informations défavorables matérielles non divulguées et inclut les attestations standard prévues par la Rule 144.

Alector, Inc. (ALEC) hat ein Formular 144 eingereicht und einen geplanten Verkauf von 76,446 Stammaktien mit einem Gesamtmarktwert von $152,892.00 gemeldet, bei insgesamt 101,212,329 ausstehenden Aktien. Die Einreichung gibt an, dass die Aktien am 03/01/2023 als restricted stock erworben wurden und nennt ein voraussichtliches Verkaufsdatum am 08/08/2025 an der NASDAQ über Morgan Stanley Smith Barney LLC. Die Mitteilung legt außerdem einen vorherigen Verkauf von 16,488 Aktien am 06/02/2025 mit Bruttoerlösen von $22,065.89 offen. Der Unterzeichner erklärt, dass keine nicht offengelegten, wesentlichen nachteiligen Informationen vorliegen, und fügt die üblichen Bestätigungen gemäß Rule 144 bei.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Insider plans a small, compliant sale of restricted shares; size is immaterial to capitalization.

The Form 144 notifies the market of a proposed sale of 76,446 restricted shares valued at $152,892, representing roughly 0.08% of the reported 101.2 million shares outstanding. From a market-impact standpoint this is immaterial to equity capitalization and likely will not affect trading liquidity or valuation. The filing names Morgan Stanley Smith Barney as broker and provides an approximate sale date, which supports regulatory transparency but does not imply material company-level change.

TL;DR: Filing demonstrates routine insider compliance with Rule 144; disclosures are standard and include prior recent sale.

The notice documents acquisition as restricted stock on 03/01/2023 and confirms the required attestation that no undisclosed material adverse information exists. The inclusion of a recent sale on 06/02/2025 for 16,488 shares shows prior deleveraging by the reporting person. These elements indicate standard adherence to disclosure obligations rather than signaling governance concerns or material events requiring investor action.

Alector, Inc. (ALEC) ha presentato un Form 144 segnalando la proposta di vendita di 76,446 azioni ordinarie per un valore di mercato complessivo di $152,892.00, su 101,212,329 azioni in circolazione. Il deposito indica che le azioni sono state acquisite come restricted stock il 03/01/2023 e riporta una data approssimativa di vendita del 08/08/2025 sul NASDAQ tramite Morgan Stanley Smith Barney LLC. L'avviso segnala inoltre una precedente vendita di 16,488 azioni il 06/02/2025 per proventi lordi di $22,065.89. Il sottoscrittore dichiara che non esistono informazioni sfavorevoli materiali non divulgate e include le attestazioni standard previste dalla Rule 144.

Alector, Inc. (ALEC) presentó un Form 144 informando una propuesta de venta de 76,446 acciones comunes por un valor de mercado agregado de $152,892.00, de un total de 101,212,329 acciones en circulación. La presentación indica que las acciones fueron adquiridas como restricted stock el 03/01/2023 y señala una fecha aproximada de venta del 08/08/2025 en NASDAQ a través de Morgan Stanley Smith Barney LLC. El aviso también revela una venta anterior de 16,488 acciones el 06/02/2025 por ingresos brutos de $22,065.89. El firmante declara que no existe información adversa material no divulgada e incluye las atestaciones estándar de la Rule 144.

Alector, Inc. (ALEC)는 Form 144를 제출하여 총 시장 가치가 $152,892.0076,446 보통주 매각 예정 사실을 보고했으며, 발행 주식 수는 101,212,329입니다. 제출 문서에 따르면 해당 주식은 03/01/2023restricted stock으로 취득되었고, 08/08/2025NASDAQ을 통해 Morgan Stanley Smith Barney LLC에서 매각될 예정으로 기재되어 있습니다. 또한 공지에는 06/02/202516,488주를 매각하여 총수익 $22,065.89를 얻었다는 사실도 공개되어 있습니다. 서명인은 공개되지 않은 중대한 불리한 정보가 없음을 진술하며 Rule 144의 표준 확인서들을 포함합니다.

Alector, Inc. (ALEC) a déposé un Form 144 déclarant une vente proposée de 76,446 actions ordinaires pour une valeur marchande totale de $152,892.00, sur 101,212,329 actions en circulation. Le dossier précise que les actions ont été acquises en tant que restricted stock le 03/01/2023 et indique une date approximative de vente au 08/08/2025 sur le NASDAQ via Morgan Stanley Smith Barney LLC. L'avis divulgue également une vente antérieure de 16,488 actions le 06/02/2025 pour un produit brut de $22,065.89. Le signataire déclare l'absence d'informations défavorables matérielles non divulguées et inclut les attestations standard prévues par la Rule 144.

Alector, Inc. (ALEC) hat ein Formular 144 eingereicht und einen geplanten Verkauf von 76,446 Stammaktien mit einem Gesamtmarktwert von $152,892.00 gemeldet, bei insgesamt 101,212,329 ausstehenden Aktien. Die Einreichung gibt an, dass die Aktien am 03/01/2023 als restricted stock erworben wurden und nennt ein voraussichtliches Verkaufsdatum am 08/08/2025 an der NASDAQ über Morgan Stanley Smith Barney LLC. Die Mitteilung legt außerdem einen vorherigen Verkauf von 16,488 Aktien am 06/02/2025 mit Bruttoerlösen von $22,065.89 offen. Der Unterzeichner erklärt, dass keine nicht offengelegten, wesentlichen nachteiligen Informationen vorliegen, und fügt die üblichen Bestätigungen gemäß Rule 144 bei.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Alector

NASDAQ:ALEC

ALEC Rankings

ALEC Latest News

ALEC Latest SEC Filings

ALEC Stock Data

142.99M
89.36M
10.61%
81.28%
5.87%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
SOUTH SAN FRANCISCO